Bret Bogue: Apothecary Genetics

He’s setting out to bring Apothecary Genetics to the forefront as the leading brand for cannabis seed distribution and development. So, obviously we don’t have to prove further that Bret Bogue has no shortage of ambition. He’s extended their reach far past national boarders to other countries and are already growing to become a household name in the global cannabis market. Absolutely eye-opening, mind-expanding, and thought-provoking information in our interview with the mastermind of the seed from which our industry grows…

What was the deciding factor for you to join this particular industry?

Derwin Wallace: CannaWebcast

Whether you’re a grower, a dispensary owner, a product developer, or a consultant in the cannabis industry… you have hopefully realized the importance of putting yourself, your company, and your mission out there for investors and members of the media alike. The only obstacle is time and finances, but that’s what Derwin Wallace of CannaWebcast has sought to alleviate with his monthly online meeting that is putting entrepreneurs and investors from across the nation into the same room without even a thought of an airline ticket. Now, how creative is that?

While the subject of industrialhemp may be on the lips of millions of people today, in currenthemp news, and certainly on the minds of researchers and farmers alike, some of the value regarding this crop might not be the most talked about subject among the average Joe. The benefits of having a plant that can grow in almost any soil, with very minimal maintenance, and that can be used for virtually everything, might not be on the forefront of most folk’s minds.

The Latin American and Caribbean Center and the Universidad Católica del Uruguay have partnered to conduct a research project on the legalization of marijuana and the transformation of drug policy.

In 2013, Uruguay passed a bill regulating the production, distribution and consumption of marijuana. For Jose Miguel Cruz, director of research at the university’s LACC, this was the ideal situation for an experiment.

“The point of the project was not to advocate, or oppose, the legalization of marijuana,” Cruz said. “We really want to know, in terms of policy, what happens when you change your approach toward drugs.”

(Photo courtesy of Greg de Hoedt / the Brighton Cannabis Club)

France is no Amsterdam when it comes to marijuana laws, in fact it has some of the toughest possession statutes in Europe, but a first of its kind bill proposed this week could change that. The lawmaker behind the legislation tells The Local why marijuana should be legalized in France.

People smoking a joint in France face a maximum penalty of a year behind bars and a €3,750 fine for the first offence, yet 13.4 million French people admit to sparking up at least once in their life. Even France’s top cop, Interior Minister Manuel Vallls, said in a recent interview, he’d tried it “maybe once.”

The marijuana industry is booming, and it doesn't show any signs of slowing down in the near future.

• This is the third in our series on medical marijuana for bipolar. In the first piece, we made a conditional case for marijuana to treat bipolar, with some major provisos. The second piece compared the risk/benefits of medical marijuana with prescription drugs.

  In this installment, we look at the endocannabis system that marijuana acts upon.

   

This is a follow-up to last week’s post on medical marijuana for bipolar. In the post, I noted that a case can be made for using the product in very small doses to relieve symptoms and maintain mental health, but with some very strong provisos.

In particular, I noted: 

All medications, including psychiatric meds, carry substantial risks that must be weighed against potential benefits. Marijuana is no exception.

I also pointed out: